Pfizer (PFE) Price to Book (2009 - 2026)

Pfizer (PFE) has reported Price to Book for 18 consecutive years, with 1.62 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 4.81% year-over-year to 1.62 in Q2 2026; TTM through Jun 2026 was 1.62, a 4.81% increase from a year earlier, with the FY2025 full-year figure at 1.63, down 3.96% from the prior year.
• Price to Book was 1.62 for Q2 2026 at Pfizer, down from 1.7 in the prior quarter.
• Over five years, Price to Book peaked at 13.15 in Q3 2022 and troughed at 1.45 in Q3 2025.
• A 5-year average of 3.04 and a median of 1.79 in 2024 frame the typical range for Price to Book.
• Across the five-year window, Price to Book surged 314.46% in 2022 and plunged 80.06% in 2024, its largest moves.
• Over 5 years, Price to Book stood at 3.0 in 2022, then tumbled by 39.35% to 1.82 in 2023, then fell by 6.69% to 1.7 in 2024, then retreated by 3.96% to 1.63 in 2025, then decreased by 0.75% to 1.62 in 2026.
• The last three Price to Book figures came in at 1.62 (Q2 2026), 1.7 (Q1 2026), and 1.63 (Q4 2025), per Business Quant data.